- Home
- CELH vs RGC Comparison
CELH vs RGC Comparison
Compare CELH & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELH | RGC |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 13.2B |
| IPO Year | 2008 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CELH | RGC |
|---|---|---|
| Price | $58.08 | $26.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $66.19 | N/A |
| AVG Volume (30 Days) | ★ 4.2M | 155.6K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $1,318,014,000.00 | N/A |
| Revenue This Year | $83.24 | N/A |
| Revenue Next Year | $32.61 | N/A |
| P/E Ratio | $230.05 | ★ N/A |
| Revenue Growth | ★ 101.65 | N/A |
| 52 Week Low | $24.04 | $3.99 |
| 52 Week High | $66.74 | $950.00 |
Technical Indicators
Market Signals| Indicator | CELH | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 69.85 | 46.96 |
| Support Level | $41.58 | $24.31 |
| Resistance Level | $57.85 | $36.75 |
| Average True Range (ATR) | 2.05 | 2.63 |
| MACD | 0.94 | -0.44 |
| Stochastic Oscillator | 90.65 | 9.90 |
Price Performance
Historical ComparisonAbout CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.